FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Zydus Pharmaceuticals (USA) clomiPRAMINE Hydrochloride Recall

clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC…

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Nov 12, 2025
Recall ID
D-0152-2026
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals (USA) recalled clomiPRAMINE Hydrochloride starting Oct 22, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0152-2026 on Nov 12, 2025. Reason: cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. Status: Ongoing.

Why it was recalled

cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.

Product description

clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottles (NDC 16714-849-02), c) 100-count bottles (NDC 16714-849-03), Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India

Lot numbers, UPCs & expiration codes

a) Lot # E408871, Exp Date: 10/2026; Lot # E405282, Exp Date: 06/2026; Lot # E400386, Exp Date: 12/2025 b) Lot # E408872, Exp Date: 10/2026; Lot # E405280, Exp Date: 06/2026 c) Lot # E408873, Exp Date: 10/2026; Lot # E405281, Exp Date: 06/2026; Lot # E400387, Exp Date: 12/2025

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0152-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 22, 2025
FDA report date
Nov 12, 2025
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals (USA) Inc

Original FDA data

Every field from FDA enforcement report D-0152-2026, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Ongoing
Country
United States
Event ID
97856
Address
73 Route 31 N
Code information
a) Lot # E408871, Exp Date: 10/2026; Lot # E405282, Exp Date: 06/2026; Lot # E400386, Exp Date: 12/2025 b) Lot # E408872, Exp Date: 10/2026; Lot # E405280, Exp Date: 06/2026 c) Lot # E408873, Exp Date: 10/2026; Lot # E405281, Exp Date: 06/2026; Lot # E400387, Exp Date: 12/2025
Postal code
08534-3601
Report date
Nov 12, 2025
Product type
Drugs
Recall number
D-0152-2026
Classification
Class II
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Reason for recall
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottles (NDC 16714-849-02), c) 100-count bottles (NDC 16714-849-03), Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India
Distribution pattern
Nationwide in the US
Recall initiation date
Oct 22, 2025
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Nov 4, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0152-2026, published Nov 12, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls